Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shobha Purushothama

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
The AAPS Journal|September 7, 2014
Next generation ligand binding assays-review of emerging technologies' capabilities to enhance throughput and multiplexingJohanna Mora, Allison Given Chunyk, Mark Dysinger, et al.
Bioanalysis|January 19, 2018
Emerging technologies for biotherapeutic bioanalysis from a high-throughput and multiplexing perspective: insights from an AAPS emerging technology action program committeeShobha Purushothama, Mark Dysinger, Yao Chen, et al.
Bioanalysis|December 13, 2019
Well-developed ligand-binding assays demonstrate robust performance using singlet analysisDouglas Donaldson, Shobha Purushothama, Eric David, et al.
Journal of Immunological Methods|August 25, 2016
Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg/mL levels of cytokines in human serumDavid Yeung, Shawn Ciotti, Shobha Purushothama, et al.
Bioanalysis|May 7, 2013
Bioanalysis of antibody-drug conjugates: American Association of Pharmaceutical Scientists Antibody-Drug Conjugate Working Group position paperBoris Gorovits, Stephen C Alley, Sanela Bilic, et al.
The AAPS Journal|November 8, 2017
Recommendations for the Assessment and Management of Pre-existing Drug-Reactive Antibodies During Biotherapeutic DevelopmentLi Xue, Adrienne Clements-Egan, Lakshmi Amaravadi, et al.
The AAPS Journal|January 30, 2016
Pre-existing Antibody: Biotherapeutic Modality-Based ReviewBoris Gorovits, Adrienne Clements-Egan, Mary Birchler, et al.
The AAPS Journal|December 2, 2021
Anti-drug Antibody Validation Testing and Reporting HarmonizationHeather Myler, João Pedras-Vasconcelos, Kelli Phillips, et al.
Bioanalysis|May 17, 2022
2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness (<u>Part 3</u> - Recommendations on Gene Therapy, Cell Therapy, Vaccine Assays; Immunogenicity of Biotherapeutics and Novel Modalities; Integrated Summary of Immunogenicity Harmonization)Lina Loo, Shannon Harris, Mark Milton, et al.
Bioanalysis|November 30, 2018
2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3 - LBA/cell-based assays: immunogenicity, biomarkers and PK assays)Lauren Stevenson, Susan Richards, Renuka Pillutla, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The AAPS Journal|September 7, 2014
Next generation ligand binding assays-review of emerging technologies' capabilities to enhance throughput and multiplexingJohanna Mora, Allison Given Chunyk, Mark Dysinger, et al.
Bioanalysis|January 19, 2018
Emerging technologies for biotherapeutic bioanalysis from a high-throughput and multiplexing perspective: insights from an AAPS emerging technology action program committeeShobha Purushothama, Mark Dysinger, Yao Chen, et al.
Bioanalysis|December 13, 2019
Well-developed ligand-binding assays demonstrate robust performance using singlet analysisDouglas Donaldson, Shobha Purushothama, Eric David, et al.
Journal of Immunological Methods|August 25, 2016
Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg/mL levels of cytokines in human serumDavid Yeung, Shawn Ciotti, Shobha Purushothama, et al.
Bioanalysis|May 7, 2013
Bioanalysis of antibody-drug conjugates: American Association of Pharmaceutical Scientists Antibody-Drug Conjugate Working Group position paperBoris Gorovits, Stephen C Alley, Sanela Bilic, et al.
The AAPS Journal|November 8, 2017
Recommendations for the Assessment and Management of Pre-existing Drug-Reactive Antibodies During Biotherapeutic DevelopmentLi Xue, Adrienne Clements-Egan, Lakshmi Amaravadi, et al.
The AAPS Journal|January 30, 2016
Pre-existing Antibody: Biotherapeutic Modality-Based ReviewBoris Gorovits, Adrienne Clements-Egan, Mary Birchler, et al.
The AAPS Journal|December 2, 2021
Anti-drug Antibody Validation Testing and Reporting HarmonizationHeather Myler, João Pedras-Vasconcelos, Kelli Phillips, et al.
Bioanalysis|May 17, 2022
2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness (<u>Part 3</u> - Recommendations on Gene Therapy, Cell Therapy, Vaccine Assays; Immunogenicity of Biotherapeutics and Novel Modalities; Integrated Summary of Immunogenicity Harmonization)Lina Loo, Shannon Harris, Mark Milton, et al.
Bioanalysis|November 30, 2018
2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3 - LBA/cell-based assays: immunogenicity, biomarkers and PK assays)Lauren Stevenson, Susan Richards, Renuka Pillutla, et al.
Pageof 3